These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 220823)

  • 1. [Pathogenetic therapy of nervous system and muscular diseases using large doses of prednisolone on alternate days].
    Gekht BM; Kuzin MI; Kolomenskaia EA; Gnezditskaia EV; Zefirova GS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(3):286-90. PubMed ID: 220823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and adverse effects of using large doses of corticosteroid preparations administered every other day].
    Kolomenskaia EA; Andreeva II; Ibragimova GV; Odintsova TA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(4):531-6. PubMed ID: 6305069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of neurologic diseases with synthetic corticotropin (beta-1-24-corticotropin)].
    Steinbrecher W
    Med Welt; 1969 Nov; 48():2636-49. PubMed ID: 4318400
    [No Abstract]   [Full Text] [Related]  

  • 4. [Strategy for using glucocorticoid preparations in neuromuscular diseases].
    Gekht BM; Kolomenskaia EA; Shagal DI; Merkulova DM; Ibragimova GV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(11):1651-8. PubMed ID: 3002079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Steroid therapy for neurologic diseases--indications and methods of administration].
    Takatsu M; Toyokura Y
    Nihon Rinsho; 1979 Jun; 37(6):1308-15. PubMed ID: 225590
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with intrathecal corticosteroid treatment of polysclerosis and other neurological diseases].
    Schmidt E
    Psychiatr Neurol Med Psychol (Leipz); 1967 Apr; 19(4):152-6. PubMed ID: 6072684
    [No Abstract]   [Full Text] [Related]  

  • 7. [Principles and limits of ACTH-cortisone therapy in neurology].
    Bammer HG
    Bibl Psychiatr Neurol; 1969; 139():36-59. PubMed ID: 4332888
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenetic therapy of diseases of the nervous system and muscles with large doses of prednisolone on alternate days.
    Gekht BM; Kuzin MI; Kolomenskaya EA; Gnezditskaya EV; Zefirova GS; Ibragimova GV; Ippolitov IK; Kuralesin MG; Polykovskaya ID; Shagal DI
    Neurosci Behav Physiol; 1981; 11(4):363-6. PubMed ID: 7343875
    [No Abstract]   [Full Text] [Related]  

  • 9. [Corticoid and ACTH therapy of neurologic diseases].
    Hallen O
    Med Welt; 1973 Jun; 24(23):951-4. PubMed ID: 4355430
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of alternate-day prednisolone administration on hypophyseal-adrenocortical activity in dogs.
    Brockus CW; Dillon AR; Kemppainen RJ
    Am J Vet Res; 1999 Jun; 60(6):698-702. PubMed ID: 10376895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroids in neurology.
    Wiles CM
    Br J Hosp Med; 1982 Oct; 28(4):308, 313-6, 321-2. PubMed ID: 7139155
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunodepressive agents in neurology].
    Sabouraud O
    Rev Prat; 1986 Jan; 36(5):229-36. PubMed ID: 2870559
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunosuppressive therapy of various autoimmune diseases of the nervous system].
    Neretin VIa; Odinokova VA; Kir'iakov VA; Sapfirova VA
    Sov Med; 1990; (12):31-5. PubMed ID: 2097756
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
    Straub RH; Pongratz G; Schölmerich J; Kees F; Schaible TF; Antoni C; Kalden JR; Lorenz HM
    Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the clinical and immunological indices of patients with disseminated sclerosis being treated with prednisolone].
    Iarosh AA; Tiazhkorob AM; Prokopiv MM; Kanevskaia SA; Zhovnir IK
    Vrach Delo; 1991 Dec; (12):61-3. PubMed ID: 1792777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of alternate-day corticosteroid administration in the treatment of polymyositis].
    Uchino M; Araki S; Yoshida O; Uekawa K; Nagata J
    Rinsho Shinkeigaku; 1983 Oct; 23(10):842-6. PubMed ID: 6673865
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with intrathecal glucocorticoid therapy in inflammatory neurological diseases (35 case reports)].
    Göpel W; Bertram W
    Z Arztl Fortbild (Jena); 1971 Jan; 65(2):99-103. PubMed ID: 5109213
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebrospinal fluid ACTH and cortisol in opsoclonus-myoclonus: effect of therapy.
    Pranzatelli MR; Chun KY; Moxness M; Tate ED; Allison TJ
    Pediatr Neurol; 2005 Aug; 33(2):121-6. PubMed ID: 16087057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of corticosterone in human hypothalamic-pituitary-adrenal axis feedback.
    Raubenheimer PJ; Young EA; Andrew R; Seckl JR
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):22-6. PubMed ID: 16817814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human corticotropin-releasing factor plus lysine vasopressin test during glucocorticoid therapy.
    Hashimoto K; Suemaru S; Takao T; Sugawara M; Hattori T; Kageyama J; Takahashi K; Ota Z
    J Clin Invest; 1988 Jul; 82(1):13-6. PubMed ID: 2839544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.